News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

OSI Pharmaceuticals, Inc. (OSIP) Updates Status Of Pending Acquisition Of Eyetech Pharmaceuticals, Inc. (EYET)


11/10/2005 1:27:37 PM

MELVILLE, N.Y.--(BUSINESS WIRE)--Nov. 10, 2005--OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) provided an update today on the status of its pending acquisition of Eyetech Pharmaceuticals, Inc. (Nasdaq:EYET). Eyetech held its special meeting of stockholders today to consider adoption of the merger agreement with OSI. At that meeting, the majority of Eyetech's outstanding shares of common stock were voted in favor of adoption of the merger agreement.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES